open access

Vol 10, No 2 (2014)
Congress abstract / Abstract
Published online: 2014-05-14
Get Citation

ESMO Symposium on Immuno-Oncology 2013 in Geneva

Magdalena Zaborowska-Szmit
Onkol. Prak. Klin 2014;10(2):112-120.

open access

Vol 10, No 2 (2014)
Sprawozdania
Published online: 2014-05-14

Abstract

The article is the report from the ESMO Symposium on Immuno-Oncology, which was held on November 15–16, 2013, in Geneva. The efficacy of immunotherapy in patients with non-small cell lung cancer or melanoma was presented. The famous international Experts discussed some possible criteria for evaluation of response during anticancer treatment using antibodies targeted against the CTLA-4 and PD-1 receptors as well as against programmed death-ligand (PDL-1). Predictive values of selected biomarkers were shown.

Abstract

The article is the report from the ESMO Symposium on Immuno-Oncology, which was held on November 15–16, 2013, in Geneva. The efficacy of immunotherapy in patients with non-small cell lung cancer or melanoma was presented. The famous international Experts discussed some possible criteria for evaluation of response during anticancer treatment using antibodies targeted against the CTLA-4 and PD-1 receptors as well as against programmed death-ligand (PDL-1). Predictive values of selected biomarkers were shown.

Get Citation

Keywords

immuno-oncology, lung cancer, melanoma, biomarkers

About this article
Title

ESMO Symposium on Immuno-Oncology 2013 in Geneva

Journal

Oncology in Clinical Practice

Issue

Vol 10, No 2 (2014)

Article type

Congress abstract / Abstract

Pages

112-120

Published online

2014-05-14

Bibliographic record

Onkol. Prak. Klin 2014;10(2):112-120.

Keywords

immuno-oncology
lung cancer
melanoma
biomarkers

Authors

Magdalena Zaborowska-Szmit

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl